Value proposition of PSMA-targeted α-particle radioligand therapy in metastatic prostate cancer.

Jadvar, Hossein.
Eur J Nucl Med Mol Imaging; 46(1): 8-10, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30310953